Impact of maternal methylenetetrahydrofolate reductase C677T polymorphism on intervillous and decidual pathology with pregnancy loss.
Impact of maternal methylenetetrahydrofolate reductase C677T polymorphism on intervillous and decidual pathology with pregnancy loss.
复制标题
母体亚甲基四氢叶酸还原酶 C677T 多态性对妊娠丢失的绒毛间和蜕膜病理的影响。
DOI:
10.1111/jog.13798
复制
发表时间:
2019
期刊:
影响因子:
--
通讯作者:
et al.,
中科院分区:
文献类型:
--
作者:
Mehandjiev TR;Tenno NM;Yanagihara I;et al.,
AimThe association between methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and intervillous and decidual pathology in patients with pregnancy loss was investigated.MethodsWe performed a cross‐sectional study on 243 patients presenting with pregnancy loss for the degree of intervillous fibrin and thrombosis (IT), and decidual fibrin and thrombosis (DT) and determined theirMTHFRC677T genotypes. Overall differences in age, body mass index (BMI), gravidity, parity, number of pregnancy losses and gestational period when the pathologic samples were obtained, also were determined.ResultsThere were no significant differences in age, BMI, gravidity, parity, number of pregnancy losses and gestational period, relative toMTHFRC677T genotype (TT vs CT vs CC). There were significantly more T allele carriers and TT genotype patients among patients with severe IT (odds ratio [OR] 1.653,P= 0.033 and OR 2.246,P= 0.032, respectively) and those with severe IT and decidual thrombosis (OR 2.602,P= 0.012 and OR 3.375,P= 0.035, respectively). The CC genotype was protective against the four studied pathologic grades.ConclusionTo our knowledge, this is the first study showing that theMTHFRC677T TT genotype and T allele are associated with severe intervillous and decidual pathologies in patients with pregnancy loss. Differences in pathologic grades ofMTHFRC677T TT genotype could support the hypothesis that further periconceptional treatment for pregnancy loss could be customized depending on single nucleotide polymorphisms.